CLINICAL_TRIALS
trial_result
· 2026-08-05
Clinical Trial Update: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) [Phase 3]
Summary
Phase 3 clinical trial update for Enlicitide (MK-0616-037) in participants with hyperlipidemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hyperlipidemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING